ArticleResearch square2023

Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis: an open-label, phase 2 trial.

Ragha V Suresh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.